Literature DB >> 11830468

3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography.

Svetla Stoilova-McPhie1, Bruno O Villoutreix, Koen Mertens, Geoffrey Kemball-Cook, Andreas Holzenburg.   

Abstract

Despite recent studies, the organization of coagulation factor VIII (FVIII) on a phospholipid (PL) membrane is not known in detail. Thus, 2-dimensional (2D) crystals of human FVIII lacking the B domain were prepared for electron microscopy onto negatively charged PL monolayers. The 3-dimensional (3D) density map of the PL-bound FVIII protein was calculated at 1.5 nm. Existing atomic data and models for FVIII domains were fitted unambiguously within the 3D density map of the molecule. FVIII domains arrangement followed a compact spiral organization with the A3 domains in close association with the C1 and C2 domains near the PL surface. Viewed toward the membrane the A domains' heterotrimer is oriented side-on with the pseudo-3-fold axis almost parallel to the PL surface and A1 fully covering C1. The C2 domain is partially overlapped by the A2 domain of an adjacent molecule in the 2D crystal, favoring close packing. Viewed parallel to the membrane, C2 is slightly inclined to the PL surface covering an area of 12 nm(2). Four C2 loops are embedded within the lipid monolayer at about 0.7 to 1.0 nm depth. C1 forms almost a right angle with C2, its long axis nearly parallel to the membrane. The proposed structure for membrane-bound FVIII results from modeling of the FVIII domains within a 3D density map obtained from electron crystallography and accords with the main biochemical and structural information known to date. A model is proposed for FVIIIa and factor IXa assembly within the membrane-bound factor X-activating complex. (Blood. 2002;99:1215-1223)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830468     DOI: 10.1182/blood.v99.4.1215

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex.

Authors:  Vivek S Purohit; Karthik Ramani; Rita Sarkar; Haig H Kazazian; Sathyamangalam V Balasubramanian
Journal:  J Biol Chem       Date:  2005-02-23       Impact factor: 5.157

3.  Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.

Authors:  Vijaya L Simhadri; Nobuko Hamasaki-Katagiri; Brian C Lin; Ryan Hunt; Sujata Jha; Sandra C Tseng; Andrew Wu; Amber A Bentley; Ran Zichel; Qi Lu; Lily Zhu; Darón I Freedberg; Dougald M Monroe; Zuben E Sauna; Robert Peters; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  J Med Genet       Date:  2016-12-22       Impact factor: 6.318

Review 4.  Regulation of the protein C anticoagulant and antiinflammatory pathways.

Authors:  A R Rezaie
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake.

Authors:  Esther Bloem; Maartje van den Biggelaar; Aleksandra Wroblewska; Jan Voorberg; Johan H Faber; Marianne Kjalke; Henning R Stennicke; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2013-09-05       Impact factor: 5.157

6.  Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.

Authors:  Zhuo Liu; Lin Lin; Cai Yuan; Gerry A F Nicolaes; Liqing Chen; Edward J Meehan; Bruce Furie; Barbara Furie; Mingdong Huang
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

Review 7.  Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity.

Authors:  Takehisa Kitazawa; Midori Shima
Journal:  Int J Hematol       Date:  2018-10-22       Impact factor: 2.490

8.  Domain organization of membrane-bound factor VIII.

Authors:  Svetla Stoilova-McPhie; Gillian C Lynch; Steven Ludtke; B Montgomery Pettitt
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

9.  Helical organization of blood coagulation factor VIII on lipid nanotubes.

Authors:  Jaimy Miller; Daniela Dalm; Alexey Y Koyfman; Kirill Grushin; Svetla Stoilova-McPhie
Journal:  J Vis Exp       Date:  2014-06-03       Impact factor: 1.355

Review 10.  Progress in the understanding of the protein C anticoagulant pathway.

Authors:  Björn Dahlbäck
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.